← Eichor
Condition: Hit Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hit

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma
NA · 1 location(s) · Erasmus Medical Center · NCT06183983Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Thera
Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06140966Technology Supported High Intensity Training in Chronic Low Back Pain: the Techno-HIT Trial
NA · 4 location(s) · Hasselt University · NCT06491121Training for Men Undergoing Androgen Deprivation Therapy.
NA · 1 location(s) · The Swedish School of Sport and Health Sciences · NCT06449664Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thromboc
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT06033300International HIT-MED Registry (I-HIT-MED)
Phase N/A · 57 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT02417324Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Ly
Phase N/A · 20 location(s) · Fondazione Italiana Linfomi - ETS · NCT06588205Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Phase 2 · 77 location(s) · Allogene Therapeutics · NCT06500273A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies
Phase 1/Phase 2 · 11 location(s) · IDP Discovery Pharma S.L. · NCT05908409Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS)
Phase N/A · 1 location(s) · Northwestern University · NCT06804785A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcita
Phase 2 · 53 location(s) · Hoffmann-La Roche · NCT06806033DVRd in the Treatment of Patients With Newly Diagnosed Double-hit Multiple Myeloma
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06158269HIT-Stroke Trial 2
NA · 3 location(s) · University of Cincinnati · NCT06268041Pharmacogenomics of Heparin-Induced Thrombocytopenia
Phase N/A · 1 location(s) · University of Arizona · NCT02717039Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty
NA · 1 location(s) · Hip Innovation Technology · NCT02836262Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Ly
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT03136146Safety and Effectiveness of the HIT Reverse HRS
NA · 6 location(s) · Hip Innovation Technology · NCT05357378Leflunomide to Prevent Cytomegalovirus Reactivation in Stem Cell Transplant Patients
Phase 2 · 3 location(s) · Tata Memorial Centre · NCT07709013A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
EARLY_Phase 1 · 21 location(s) · Nationwide Children's Hospital · NCT04655404
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.